SHAWN SAGER: Open Payments
NPI 1639692254 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 22 payments from 13 companies in 2025. Trend: 2023 $247 · 2024 $123 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $70 |
| Lilly USA, LLC | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $44 |
| ABIOMED | 1 | $30 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
Products named: VRAYLAR, MOUNJARO, CAPLYTA, TRELEGY ELLIPTA, DUPIXENT, VOQUEZNA, QULIPTA, Kerendia.
Industry payments across OK — which companies pay providers there.
